Select groups |
---|
Serum | Plasma » |
PCR | Viral serum matrix » |
R&D | assay validation » |
Pre-clinical specimen | Patient samples » |
Human Plasma |
||
---|---|---|
Code | Specificity | Form |
NP0130 | anti-HBs neg. source | single |
NP0210 | anti-HBs neg. source, customized | single |
NP0230 | anti-HBs & anti-HBc neg source | single |
NP1201 | anti-HTLV I/II negative source | single |
NP1230 | anti-HBs & anti-HBc & anti-HTLV- I/II neg source | single |
Custom Anticoagulants |
||
---|---|---|
Code | Specificity | Form |
NP0110 | ACDA Plasma | single / pooled |
NP0200 | Human Plasma, Citrate | single / pooled |
NP0300 | Normal Plasma CPD | single / pooled |
NP0990 | Normal Plasma, Lithium Heparin | single / pooled |
NP0992 | Normal Plasma, K3 EDTA | single / pooled |
NP0993 | Normal Plasma, Na2 EDTA | single / pooled |
NP0995 | Normal Plasma, Sodium Heparin | single / pooled |
Human Whole Blood & Blood Components |
||
---|---|---|
Code | Specificity | Form |
SN0001 | Whole Blood | single |
SN0010 | Erythrocyte Concentrate | single / pooled |
NP0020 | Red Blood Cells (Na2 EDTA) | single / pooled |
SN0050 | Buffy Coats | single |
SN0060 | SAG-M red Cells Concentrate | liquid |
SN0992 | K3 EDTA Whole Blood | frozen |
Viral positive Bulk0.5 – 200 ml, serum and plasma fully tested and characterized |
||||
---|---|---|---|---|
Marker | Viral load | Genotype | Serology | Sequence / Mutation |
WNV | • | • | ||
HIV | • | • | ||
HCV | • | • | • | • |
HBV | • | • | • | • |
Parvo B19 | • | |||
CMV | • | • | • | |
HAV | • | • | • |
Clinical Specimen |
Over 50’000 donors for biospecimen from globally different diagnostic and demographic individuals. (Europe,
Asia, Americas, Africa) Different Matrixes (Serum, EDTA, LiHep, etc.) & Multibleeds 1 - 800 ml per Donor. Clinical Data: Patient Data (Age / Gender / GT). Detailed Anamnesis (prospective). |
Isolated Cell Lines / PBMC& |
Customized, cryopreserved, ready to use isolated cell lines from specific selected donors. (Donor characteristics such as: Allergic / PMN enriched / vaccination boosted). The isolation protocol is designed to meet your assay's specifications. www.trinacell.com |
Assay Validation & Pre-clinical |
Technical performance validation for chemiluminescence, point of care and molecular based IVD applications: A large donor base (> 5000 Donors in any serum / plasma matrix) for positive / negative / quantifications & validations. |